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 Abstract 
Pseudomonas aeruginosa mutants PA0686, PA3102, PA3103, and PA5210 
carry transposon insertions in uncharacterized genes in the PA01 background. 
The biofilms formed by these mutants show different phenotypes than PA01, 
their wild-type counterpart. BLAST searches and phylogenomic mapping 
tools indicate that protein products of the mutated genes are involved in P. 
aeruginosa type-II secretion, which is linked to twitching motility. In this 
study, 96-well microtitre plate biofilm assays, UV/visible spectrophotometer 
analysis, and motility assays were used to demonstrate a link between type-
II secretion, twitching motility and biofilm formation. The results show that 
the PA5210 mutant forms a biofilm that is less compact than the wild-type, 
while PA0686 forms a faint biofilm. Also, the motility assays support our 
hypothesis that these mutants are defective in twitching motility.
Table of Contents 
Introduction 
Acknowledgements 
Methods and materials 
Results and discussion 
Conclusions 
References 
 i 
Introduction 
Pseudomonas aeruginosa (PA) is an opportunistic pathogen that 
causes persistent infection in humans by forming a highly organized 
microbial community called a biofilm. The biofilm is formed when 
planktonic (free-swimming) cells attach to biotic and abiotic surfaces under 
certain environmental conditions. These surface-attached cells are 10-1000 
times more resistance to traditional antibiotic therapy than planktonic cells 
(Drenkard, 2003). P. aeruginosa biofilms are linked to 10% to 20% of 
nosocomial infections, the most common sites of biofilm formation being 
catheter lines, burn wounds, cystic fibrosis lung tissue, and organ transplant 
sites (Bodey, Bolivar, Fainstein & Jadeja, 1983; Miller & Ahearn, 1987).  
Also, P. aeruginosa biofilms are a frequent cause of otitis externa in 
swimmers and osteomyelitis in puncture wounds of the feet (Sarlangue, 
Brissaud & Labreze, 2006).  The latter facts strengthen the argument that 
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understanding the genetics behind biofilm formation by P. aeruginosa is 
important in the medical field. 
The most problematic factor in the treatment of P. aeruginosa 
infections is the resistance of its biofilm to antimicrobial agents. Thus, the 
treatment would be more effective if it is to include a system designed to 
weaken the formation, structure, or attachment of the biofilm during its 
development. Profound changes occur in the gene expression profile of free-
living P. aeruginosa during biofilm formation in response to appropriate 
environmental signals (O’Toole & Kolter, 1998a; Sauer & Camper, 2001). 
Data generated using DNA microarray analysis show that about 70 P. 
aeruginosa genes (approximately 1% of genes analyzed) are differentially 
expressed in biofilms with respect to planktonic cells grown in chemostat 
cultures (Drenkard, 2003). These small numbers of important genes that are 
induced in biofilms include bacteriophage genes and genes that code for 
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proteins involved in translation, metabolism, membrane transport/secretion, 
and gene regulation (Drenkard, 2003). 
 
Figure 1- Steps in P. aeruginosa biofilm formation (O’Toole, 2007) 
The development of P. aeruginosa biofilms under static assay 
conditions can be described in four processes, as shown in figure 1. At first, 
planktonic cells are transported and reversibly attach to a surface substrate. 
Then, the surface-attached cells irreversibly form a monolayer on the surface. 
Subsequently, the cells in the monolayer begin to migrate toward 
aggregation centers known as microcolonies. Lastly, these microcolonies 
mature into complex mushroom-shaped structures covered by 
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exopolysaccharide matrix and some cells break from the biofilm as 
planktonic cells to be dispersed (O’Toole el at., 2000; O’Toole and Kolter, 
1998a). 
The goal of our research is to uncover and characterize those genes 
required for biofilm formation in the pathogenic organism P. aeruginosa. 
Through phenotypic characterization of strains carrying disrupted genes, 
including an analysis of their biofilm phenotypes, a gene’s role in biofilm 
formation can be determined. A wide range of medical applications may 
come from this because treatment in one organism may be effective across a 
broad evolutionary spectrum. There are significant morphological and 
genetic similarities between most biofilms, even those of very different 
bacterial species (Garza, 2006). 
George O’Toole provided P. aeruginosa strain PA01 mutants that 
carry transposon insertions in previously uncharacterized genes. In order to 
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determine the function of these disrupted genes, a traditional genome 
annotation approach (BLAST) was used to compare each ORF within the 
genome to GenBank®, an official NIH genetic sequence database which 
contains more than 100 gigabases of an annotated collection of all publicly 
available DNA sequences (NCBI, 2007). The BLAST search annotated the 
uncharacterized clusters of genes in PA01 strain to be involved in type-II 
secretion. Type-II secretion is the mechanism by which Gram-negative 
organisms such as P. aeruginosa export pili components, virulence factors, 
toxins, and hydrolytic enzymes that may contribute to biofilm maturation 
(Russel, M. 1998). 
Following the BLAST search, phylogenomic mapping was used to 
identify possible functional interactions between type-II secretion genes and 
other genes on the P. aeruginosa chromosome. The phylogenomic map 
groups P. aeruginosa genes/proteins on the basis of coinheritance, which is a 
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strong indicator of shared function (Srinivasan et al, 2005).  According to 
the phylogenomic map, the genes for type-II secretion are co-inherited with 
genes required for twitching motility, a surface-based motility that is known 
to be important for biofilm formation.  Thus, based on the phylogenomic 
map, the type-II secretion mutant strains under study are predicted to have a 
twitching motility and perhaps biofilm phenotypes. 
Bacterial motility is required for both biofilm pathogenesis and 
attachment to biotic and abiotic surfaces. Pseudomonas aeruginosa bacteria 
swim in liquid by using flagella to move on surfaces by means of type IV 
pili, and the extension and retraction of type IV pili powers twitching 
motility, a surface-associated movement that propels bacteria across solid or 
semi-solid substrates (Semmler et al., 1999, Skerker & Berg, 2001). From 
the results from biofilm experiments conducted by O’Toole and Kolter 
(1998a) on biofilm formation by P. aeruginosa PA14, it is speculated that 
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swimming motility might enable the bacteria to overcome repulsive forces at 
the surface–water interface so that they reach the surface, and that the 
microcolonies may be formed by twitching motility-driven cell aggregation. 
The assessment of twitching and swarming motility of P. aeruginosa utilizes 
motility assays where the phenotype of the twitching motility defective 
mutants are distinguished from the wild-type on 1.5% agar media, whereas 
swarming motility phenotype is assessed using softer, 0.4% agar. 
The 96-well microtitre plate assay is used to qualitatively 
characterize the progress of biofilm development. This static assay is often 
preferred over continuous-flow methods due to the simplicity of the 
protocols and its cost-effective nature (Garza, 2006). Also, the 96-well 
format has the capacity to screen a large number of bacterial strains at once 
and is a good visual indicator of adherent biomass stained in crystal violet 
(CV) dye (O’Toole & Kolter, 1998a and b). The results from the 96-well 
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microtitre plate assay indicated the influence of the type-II secretion 
pathway in biofilm formation. 
Spectrophotometry is used for quantitative measurement of the 
biofilm formed in the 96-well plate assay. The spectrophotometer measures 
the amount of biofilm by screening the quantity of light with a specific 
wavelength that passes through a medium. According to Beer's law, the 
amount of light absorbed by a medium is proportional to the concentration 
of the absorbing material or solute present (Fankhauser, 2005). Thus, the 
concentration of a CV-stained solute in ethanol is determined by measuring 
the absorbency of light at wavelength of 600nm, which is the maximum 
absorption wavelength of CV. 
The resistance of a biofilm can be determined by the antibacterial 
resistance assay. The quantity of the mutant P. aeruginosa cells after the 
antibacterial treatment is compared to that of the wild-type cells treated in 
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the same way.     
Mutant strains with strongest phenotypical deviation (in both 
biofilm formation and antibacterial resistance) compared to the wild-type are 
selected for a more detailed analysis, while further characterization of the 
mutants with subtle biofilm defects is postponed due to time limitation. 
The general impact of the research is to better understand the 
genetics behind pathogenic biofilm formation. The practical application of 
this information is the potential discovery of new targets for antimicrobial 
agents, and thus, new potential treatments for infections caused by P. 
aeruginosa and other biofilm-forming pathogens. 
 x 
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MATERIALS AND METHODS 
Bacterial strains and culture conditions 
   The microorganism used in this study was the opportunistic pathogenic 
bacterium P. aeruginosa.  The strain that was used is PA01.  Four PA01 
mutants were also used. P. aeruginosa was grown on plates containing LB 
and 1.5% agar. Strains were grown in a 37°C incubator overnight. Then, one 
colony was picked with a pipette tip and the colony was dispersed into 5-ml 
of liquid LB in a sterile glass tube. The liquid culture was incubated in a 
37°C shaker overnight.  
Microtitre plate biofilm assay 
   This method was designed by O’Toole and Kolter, 1998b. M63 minimal 
media (M63, MgSO4, Glucose, CAA)) is prepared with 5 ml of 1M M63, 5 
ul of 1M MgSO4 (1mM dilution), 50 ul of 20% glucose (0.2% dilution), and 
125 ul of Casamino acids (0.5% dilution) in a glass tube. Then, 50 ul (1:100 
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dilutions) of the overnight liquid cultures of the wild-type and the mutants 
were added to the M63 minimal media cocktail.  One hundred microliterl 
of M63 minimal media cocktail + bacteria cells was placed into each well of 
96-well microtitre plates. The microtitre plates were sealed with Parafilm® 
to prevent evaporation during the incubation period. The Parafilm® sealed 
microtitre plates were placed in the 37°C incubator for the desired amount of 
time (in our case, 2hr, 4hr, 6hr, 8hr, 12hr, and 24hr). By using different 
incubation times, we were able to determine the number of hours required 
for the P. aeruginosa strain to fully attach to the surface. 
   Following incubation, the planktonic cells in the wells were removed by 
turning over the plates and shaking the liquid into an empty plastic container. 
Afterwards, the 96-well plates were repeatedly submerged in a small tub of 
deionized water to wash out the planktonic bacteria that did not form a 
biofilm. The removal of unattached cells from the wells was intended to 
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reduce the number planktonic cells that stain with Crystal Violet (CV); 
planktonic cells should not be included in calculations of biofilm cell mass. 
   Each well was stained with 125 l of 0.1% CV dye and the plates were 
incubated at room temperature for 15-30 minutes. After that, the CV in the 
wells was dumped into a waste plastic container and the wells were rinsed 3-
4 times with deionized water. The plates were then blotted on a stack of 
paper towels and turned upside down to dry. A ring of CV stained biofilm 
cells was seen at the air-medium interface. 
Quantification using UV/visible spectrophotometer 
The CV in each well solubilized in a 200 ul aliquot of 95% ethanol for 15 
minutes at room temperature. In order to obtain enough material for accurate 
quantification, 15 wells, representing 3 replicates of 5 wells, were used for 
each strain.  A pipette tip was used to remove the CV-stained biofilm from 
the walls of each well. Then, the ethanol solution in 5 wells (total volume 1 
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ml) was transferred to a square-bottomed cuvette. 
   The spectrophotometer reading was taken as follows: a blank was set up 
with 95% ethanol for the baseline of zero. The blank and the sample cuvette 
containing ethanol/CV solution were read at 600 nm. For each strain and 
each time point, the CV in 3 cuvettes was averaged.  All values obtained 
for the mutant strains were normalized to those of PA01 wild type. One 
drawback to this assay was that the CV stained not only cells, but any 
material that adhered to the surface of the plate, including contaminating 
material that was not part of the biofilm. 
Twitching/swarming Motility Assay 
   The twitching/swarming motility assay was designed by O’Toole and 
Kolter (1998a). Each strain was assessed for twitching motility by stabbing 
microcolony cells into very thin 1.5% LB agar plates with a toothpick. Each 
plated included a total of 3 stabs of the same strain.  These plates were 
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incubated for 24 hours at 37°C. Strains that were capable of twitching 
motility formed a haze of growth surrounding the point of inoculation. 
   For the swarming motility assay, 0.4% LB agar plates were used. A total 
of 3 inoculations of 5 ul aliquots of liquid cultures were made per plate and 
the plates were incubated at 37°C for 24 hours. The widest expansion of 
cells in diameter from the point of inoculation was measured in millimeters 
and the colony edges were analyzed for a haze of growth with uneven edges. 
Biofilm Antibiotic Resistance Assay. 
   The biofilm antibiotic resistance assay followed the same protocol as the 
96-well plate assay over 24-hour incubation at 37°C. The solution in the 
wells was removed by shaking out the liquid into an empty container and 
adding fresh media containing different concentrations of antibiotics into the 
wells (tetracyclin, ampicilin, kanamycin, and doxycycline). An additional 24 
hour Incubation at 37°C was performed and the cells in the wells were 
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assessed for their viability by spreading the media into a clean LB plate with 
an L-shaped glass-rod. Antibiotic resistance was measured for the minimal 
anti-microbial concentration required to kill all biofilm cells. 
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Results and Discussion 
   The liquid culture for the wild-type and PA5210 often expresses a 
greenish-yellow shade. From the 96-well microtitre assay indicates that the 
PA0686 mutant does not form as strong of a biofilm as the wild-type PA01 
strain and the PA5210mutant forms a biofilm that appears to be wider than 
the wild-type biofilm. In contrast, the biofilms formed by the PA3102 and 
PA3103 mutants look similar to that of the wild type. 
Results of the 96-well Microtitre Assay 
 
Figure 2- CV stain of 24-hour biofilm cells in 96-well microtitre plates 
(Photograph provided Dr. Kimberly Murphy, 2006). 
   The differences between PA5210 mutant and wild-type biofilms are 
more evident as the incubation time increases. At the 2-hr time point, 
PA01 PA0686 PA5210 PA3103 PA3102 
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biofilms are barely visible to the eye and the width of biofilm ring of wild-
type and PA5210 mutant biofilms look similar. As time progresses from 4-12 
hours, the PA5210 mutant biofilms start to become darker and wider than 
wild-type biofilms. At the 24-hr time point, the biofilm ring of PA5210 
mutant cells is much wider and darker than wild-type biofilm rings. At all 
time points after 2 hr, the PA0686 mutant biofilm are fainter in color than its 
wild-type counterpart. 
Spectra Results (2006/7/21)
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Figure 3- Spectrophotometer reading (600nm) of CV-stained biofilm mass. 
Wild-type and mutant biofilms were CV stained after 2 hours and 24 hours 
in 96-well microtitre plates. 
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The data shown in Figure 3 indicates that at 24 hr the PA5210 
mutant and the PA3103 mutant generated more biofilm-mass than wild-type 
cells, while the PA686 and PA3102 mutants generated less biofilm mass than 
wild-type cells. For the two mutants (PA686 and PA5210) with the strongest 
biofilm phenotypes, this quantitative data is consistent with the qualitative 
data from microtitre assays. However, it should be noted a significant 
amount of variability is present in using these quantitative biofilm assays. 
For example, as shown in Figure 4, the absorbance data would sometimes 
show that the PA5210 mutant produced less 24-hour biofilm mass than wild-
type cells.  In the case of the PA0686 mutant, the absorption data 
consistently indicates less biofilm mass than wild-type cells. 
   One explanation for the variability in PA5210 mutant biofilm mass 
readings is that the PA5210 mutant biofilms might be attached more firmly 
to the plastic wells than wild-type biofilms. Therefore, it might be very 
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difficult to remove the PA5210 mutant biofilms and determine their mass. 
Also, it may be that although PA5210 forms wider biofilm than the wild-
type, the biofilm is not as thick as the wild-type. 
The results of the twitching and swarming motility assays are very 
consistent. As expected, swarming motility is not affected by disruption in 
the type-II secretion genes (Figure 4).  In the case of twitching motility, 
mutations in the PA686 and PA3103 genes produced defects, whereas 
mutations in the PA3102 and PA5210 genes did not (Figure 5).   
 
Figure 4- Twitching and swarming motility viewed under the phase-contrast 
Results of Motility Assays 
Twitch+ Twitch- Twitch+ Twitch- Twitch+ 
Wild-type PA0686 PA3102 PA3103 PA5210 
Swim+ Swim+ Swim+ Swim+ Swim+ 
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microscope (photograph provided by Dr. Kimberly Murphy, 2006). The + 
sign indicates that no motility defect was found, while a – sign indicates that 
a motility defect was found. 
The motility patterns shown in figure 5 show a rounded colony 
without a haze of growth for mutant strains PA0686 and PA3103, which 
indicates that both strains are completely defective in twitching motility. On 
the other hand, PA5210 shows a haze of growth but the edges are smooth 
and not jagged as in the wild-type strain and PA3102. This result can be 
interpreted as that swarming motility is not affected by type-II secretion 
function and the type-IV pili associated movement, such as the twitching 
motility. However, defect in twitching motility influences the structure and 
development of biofilm depending on specific locus of the disrupted gene.  
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Conclusions 
A number of proteins are differentially expressed not only between 
planktonic bacteria and bacteria within a biofilm, but also between bacteria 
within biofilms at different stages of biofilm development (Drenkard, 2003). 
From the microtitre plate assay, a progressive increase in biofilm mass is 
expected with longer incubation time. The 96-well microtitre assay results 
confirmed the pattern of increasing biofilm mass. 
The PA5210 mutant was characterized by delayed biofilm formation 
since it formed a stronger biofilm than the wild-type only after 4 hours. The 
PA0686 mutant was characterized with weak biofilm formation from the 
very beginning stages. The quantification method using the 
spectrophotometer had conflicting data with the microtitre assay due to 
problems with strongly attached biofilm dispersing in ethanol.        
Twitching strains of P. aeruginosa was found to be PA3103 which 
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formed a haze of growth that surrounded the point of inoculation, while 
PA0686 and PA3103 had none. PA5210 was special in that it formed a haze 
but the colony edge was rounded. 
Analysis of the biofilm forming phenotype of several strains has 
allowed us to further understand the connection between twitching motility 
and biofilm formation. The types of assays designed by O’Toole and Kolter 
and performed in this study allow for a simple yet effective method for 
uncovering genes involved in biofilm formation in P. aeruginosa and other 
biofilm-forming pathogens. We found that mutant PA686 is defective for 
twitching motility and biofilm development using both qualitative and 
quantitative assays. This provides a link between type II secretion 
components, twitching motility and biofim development. The PA 3103 
mutant also showed a twitching motility defect, but the difference in the 
qualitative and quantitative biofilm assay data needs to be resolved. The 
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PA3102 and PA5210 mutants showed no twitching motility defects, and as is 
the case for the PA3103 mutant, the difference in the qualitative and 
quantitative biofilm assay data needs to be resolved.  
The next step in the study of gene expressions of P. aeruginosa 
biofilm would be to make homologous recombination mutants of the PA01 
stains that correspond to the some phenotype as the transposon mutants. 
Homologous recombination knockout is a more direct way of gene 
disruption that specifies mutation in the conserved domains of the gene 
rather than in the unspecified regions as in transposon method. This 
information would allow confirmation of the role of specific genes in 
biofilm formation.   
Due to time limitation, the antibacterial resistance assay was not 
done, but this assay will be a useful tool to link future experiments to P. 
aeruginosa pathogenesis. The analysis to see if the wider biofilm formed by 
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PA5210 is actually more resistant than the wild-type will be effected to see if 
biofilm structure PA5210 is as stong as the wild-type. If the PA5210 biofilm 
does not hold up to the same antimicrobial agent concentration as the wild-
type, it will mean that the biofilm structure is actually weaker than that of 
wild-type due to a defect in twitching motility.
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